TolerRx's Death

TolerRx raised a round of funding on October 14, 2011. Investors include Dead.

TolerRx is discovering, developing, and seeking to commercialize therapies designed to treat patients by reprogramming the immune system, allowing for long-term remission of immune-related diseases - …

Articles about TolerRx's Death: